InsidersTradesSigma
Imexhs Limited Stock: price and management transactions · Australia · ASX
Follow the Imexhs Limited share price and the full management transaction log of the company, a listed equity based in Australia. Shares are listed on AU AU, under the oversight of ASX. Operating in the Healthcare & Pharma sector, Imexhs Limited has recorded 7 reports. Market capitalisation: €18.8m. The latest transaction was reported on 6 July 2026 (Sale). Among the most active insiders: Damian Banks. All data is openly available.
7
Insider Decl.
0
Thresholds
€152,733
6 ops.
Buy Volume
€12,963
1 ops.
Sell Volume
31Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 20,915 of 25,973 companies
30.1
score / 100
Value18
Quality42
FCF yld-4.4%
Earn yld-19%
EV/EBITDA·
ROE-19%
Gross mgn100%
Net mgn-9.9%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 July 2026
Declarations7 total
0.11% mcap45.7% of flowShareASXASX:2924-03108227-3A696696
0.43% mcap100.0% of flowShareASXASX:2924-03096251-3A694547
Ideal exit: 27 Feb 2027 (T+270)
0.088% mcap100.0% of flowShareASXASX:2924-03096247-3A694546
Ideal exit: 26 Feb 2027 (T+270)
0.089% mcap100.0% of flowShareASXASX:2924-03096245-3A694545
Ideal exit: 27 Feb 2027 (T+270)
0.18% mcap100.0% of flowShareASXASX:2924-03096244-3A694544
Ideal exit: 27 Feb 2027 (T+270)
0.089% mcap100.0% of flowShareASXASX:2924-03096243-3A694543
Ideal exit: 27 Feb 2027 (T+270)
ShareASXASX:2924-03090072-3A693304
Ideal exit: 6 Feb 2027 (T+270)
7 of 7 declarations
About Imexhs Limited
Imexhs Limited is a company operating in the health and pharmaceutical sector. It is listed on the XASX market.
